Smith Group Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$319K Sell
4,930
-3,182
-39% -$224K 0.02% 155
2025
Q4
$546K Buy
8,112
+722
+10% +$48.6K 0.03% 130
2025
Q3
$542K Buy
+7,390
New +$491K 0.03% 125
2022
Q1
Sell
-150
Closed -$6K 318
2021
Q4
$6K Hold
150
﹤0.01% 339
2021
Q3
$6K Hold
150
﹤0.01% 342
2021
Q2
$7K Hold
150
﹤0.01% 328
2021
Q1
$6K Sell
150
-4,290
-97% -$196K ﹤0.01% 299
2020
Q4
$190K Hold
4,440
0.01% 183
2020
Q3
$117K Sell
4,440
-850
-16% -$23.7K 0.01% 191
2020
Q2
$142K Sell
5,290
-60
-1% -$1.35K 0.01% 181
2020
Q1
$96K Hold
5,350
0.01% 218
2019
Q4
$95K Hold
5,350
﹤0.01% 241
2019
Q3
$83K Buy
5,350
+1,370
+34% +$22.6K ﹤0.01% 247
2019
Q2
$68K Hold
3,980
﹤0.01% 259
2019
Q1
$64K Sell
3,980
-12,400
-76% -$201K ﹤0.01% 288
2018
Q4
$240K Sell
16,380
-400
-2% -$6.38K 0.01% 227
2018
Q3
$305K Buy
16,780
+1,200
+8% +$21K 0.01% 223
2018
Q2
$263K Hold
15,580
0.01% 229
2018
Q1
$305K Sell
15,580
-11,400
-42% -$221K 0.01% 221
2017
Q4
$547K Hold
26,980
0.02% 201
2017
Q3
$469K Hold
26,980
0.02% 220
2017
Q2
$346K Sell
26,980
-1,200
-4% -$16K 0.01% 234
2017
Q1
$365K Sell
28,180
-20
-0.1% -$253 0.01% 210
2016
Q4
$279K Hold
28,200
0.01% 229
2016
Q3
$341K Hold
28,200
0.01% 211
2016
Q2
$243K Sell
28,200
-300
-1% -$2.96K 0.01% 232
2016
Q1
$270K Sell
28,500
-14,880
-34% -$140K 0.01% 184
2015
Q4
$752K Sell
43,380
-6,700
-13% -$107K 0.02% 186
2015
Q3
$673K Buy
+50,080
New +$1.01M 0.03% 185

Other funds holding HALO

Smith Group Asset Management's HALO Position: Q1 2026 in Review

Smith Group Asset Management reduced its Halozyme (HALO) stake by 39% in Q1 2026, selling an estimated $224K and leaving 4,930 shares worth $319K. The position accounts for 0.02% of the portfolio, ranked #155.

Smith Group Asset Management first reported a position in HALO in Q3 2015 and has held it in 29 quarters since. The position peaked at $752K in Q4 2015. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Smith Group Asset Management held 4,930 shares of Halozyme worth $319K as of Q1 2026.
  • Smith Group Asset Management sold 3,182 Halozyme shares in Q1 2026, an estimated $224K.
  • Halozyme made up 0.02% of Smith Group Asset Management's portfolio in Q1 2026, its #155 holding.
  • Smith Group Asset Management first reported a position in Halozyme in Q3 2015 and has held it in 29 quarters since.
  • Smith Group Asset Management's Halozyme position peaked at $752K in Q4 2015.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Smith Group Asset Management's 13F filing for Q1 2026, filed 18 May 2026.